1,19-Bis(1-hexylheptyl) 10-[[3-(dimethylamino)propyl](1-oxooctyl)amino]nonadecanedioate

1,19-Bis(1-hexylheptyl) 10-[[3-(dimethylamino)propyl](1-oxooctyl)amino]nonadecanedioate Suppliers list
Company Name: Shanghai Changyu Medical Technology Co. Ltd.  
Tel: +86-13301875428
Email: sales@changyuhe.com
Company Name: Shochem(Shanghai)Co.,Ltd  
Tel: +86-021-51783479 13816874662
Email: info@shochem.com
Company Name: Beijing Jin Ming Biotechnology Co., Ltd.  
Tel: 010-60605840
Email: psaitong@jm-bio.com
Company Name: Shochem(Shanghai)Co.,Ltd  
Tel: +86-021-50800795 13816874662
Email: info@shochem.com
Company Name: Hubei wei shi reagent group ltd., company  
Tel: 17771898297 13125137661
Email: 2853877621@qq.com
1,19-Bis(1-hexylheptyl) 10-[[3-(dimethylamino)propyl](1-oxooctyl)amino]nonadecanedioate Basic information
Product Name:1,19-Bis(1-hexylheptyl) 10-[[3-(dimethylamino)propyl](1-oxooctyl)amino]nonadecanedioate
Synonyms:1,19-Bis(1-hexylheptyl) 10-[[3-(dimethylamino)propyl](1-oxooctyl)amino]nonadecanedioate;Nonadecanedioic acid, 10-[[3-(dimethylamino)propyl](1-oxooctyl)amino]-, 1,19-bis(1-hexylheptyl) ester;Lipid 2-10;1,19-Bis(1-hexylheptyl) 10-[[3-(dimethylamino)propyl](1-oxooctyl)amino]nonadecanedioate(LP-01);Di(tridecan-7-yl) 10-(N-(3-(dimethylamino)propyl)octanamido)nonadecanedioate
CAS:2055939-68-7
MF:C58H114N2O5
MW:919.54
EINECS:
Product Categories:
Mol File:2055939-68-7.mol
1,19-Bis(1-hexylheptyl) 10-[[3-(dimethylamino)propyl](1-oxooctyl)amino]nonadecanedioate Structure
1,19-Bis(1-hexylheptyl) 10-[[3-(dimethylamino)propyl](1-oxooctyl)amino]nonadecanedioate Chemical Properties
Boiling point 849.7±40.0 °C(Predicted)
density 0.914±0.06 g/cm3(Predicted)
solubility Chloroform: Sparingly soluble: 1-10 mg/ml
Methanol: Sparingly soluble: 1-10 mg/ml
form Liquid
pka9.44±0.28(Predicted)
color Colorless to light yellow
Safety Information
MSDS Information
1,19-Bis(1-hexylheptyl) 10-[[3-(dimethylamino)propyl](1-oxooctyl)amino]nonadecanedioate Usage And Synthesis
UsesIonizable lipid-1 (compound II-10) is an ionizable lipid (pKa=6.16) that can be used to prepare lipid nanoparticles (LNP) with bilayer structure[1].
References[1] Thomas D Madden, et al. Lamellar lipid nanoparticles. Patent WO2019089828A1.
[2] BANERJEE S, PILLAI J. Lipid Nanoparticle Formulations for Enhanced Antituberculosis Therapy[C]. 1900: 0. DOI: 10.1016/b978-0-323-47347-7.00011-2
1,19-Bis(1-hexylheptyl) 10-[[3-(dimethylamino)propyl](1-oxooctyl)amino]nonadecanedioate Preparation Products And Raw materials
Tag:1,19-Bis(1-hexylheptyl) 10-[[3-(dimethylamino)propyl](1-oxooctyl)amino]nonadecanedioate(2055939-68-7) Related Product Information
Lipid PPz-2R1 henicosan-11-yl 9-((4-(dimethylamino)butanoyl)oxy)hexadecanoate Lipid C16-C Lipid ND-O1 2-Tetradecanol, 1,1′-[[2-[2-[4-[2-[[2-[2-[bis(2-hydroxytetradecyl)amino]ethoxy]ethyl](2-hydroxytetradecyl)amino]ethyl]-1-piperazinyl]ethoxy]ethyl]imino]bis- DSPE-PEG-OH